GE HealthCare Technologies (NASDAQ:GEHC) Upgraded to “Moderate Buy” at Royal Bank Of Canada

Royal Bank Of Canada upgraded shares of GE HealthCare Technologies (NASDAQ:GEHC) to a moderate buy rating in a report published on Tuesday morning,Zacks.com reports.

Other equities analysts have also issued reports about the company. Jefferies Financial Group reduced their price objective on GE HealthCare Technologies from $105.00 to $90.00 in a research report on Thursday, April 30th. Stifel Nicolaus set a $80.00 price target on shares of GE HealthCare Technologies in a research report on Wednesday, April 29th. BTIG Research lowered their price objective on shares of GE HealthCare Technologies from $85.00 to $80.00 and set a “buy” rating for the company in a report on Wednesday, April 29th. Piper Sandler reduced their target price on shares of GE HealthCare Technologies from $88.00 to $74.00 in a report on Thursday, April 30th. Finally, HSBC decreased their target price on shares of GE HealthCare Technologies from $100.00 to $90.00 in a research report on Thursday, April 30th. Ten research analysts have rated the stock with a Buy rating and nine have given a Hold rating to the company’s stock. According to MarketBeat.com, GE HealthCare Technologies has an average rating of “Moderate Buy” and a consensus price target of $80.20.

GE HealthCare Technologies Stock Performance

GE HealthCare Technologies stock opened at $63.72 on Tuesday. The firm’s fifty day moving average price is $65.04 and its 200-day moving average price is $74.28. The company has a debt-to-equity ratio of 0.95, a quick ratio of 0.95 and a current ratio of 1.22. The stock has a market cap of $28.99 billion, a P/E ratio of 15.24, a price-to-earnings-growth ratio of 1.65 and a beta of 0.74. GE HealthCare Technologies has a fifty-two week low of $58.75 and a fifty-two week high of $89.77.

GE HealthCare Technologies (NASDAQ:GEHC) last announced its earnings results on Wednesday, April 29th. The company reported $0.99 earnings per share (EPS) for the quarter, missing the consensus estimate of $1.07 by ($0.08). GE HealthCare Technologies had a return on equity of 20.46% and a net margin of 9.10%.The company had revenue of $5.13 billion during the quarter, compared to analysts’ expectations of $5.04 billion. During the same quarter last year, the firm posted $1.01 earnings per share. The firm’s revenue was up 7.4% on a year-over-year basis. GE HealthCare Technologies has set its FY 2026 guidance at 4.800-5.000 EPS. On average, equities research analysts expect that GE HealthCare Technologies will post 4.89 earnings per share for the current fiscal year.

Insider Buying and Selling at GE HealthCare Technologies

In other GE HealthCare Technologies news, insider Frank R. Jimenez bought 1,750 shares of GE HealthCare Technologies stock in a transaction dated Thursday, April 30th. The shares were purchased at an average cost of $60.45 per share, with a total value of $105,787.50. Following the completion of the purchase, the insider owned 93,932 shares of the company’s stock, valued at approximately $5,678,189.40. This represents a 1.90% increase in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at this hyperlink. Also, CFO James Saccaro purchased 3,310 shares of the business’s stock in a transaction that occurred on Friday, May 1st. The stock was bought at an average price of $60.60 per share, for a total transaction of $200,586.00. Following the acquisition, the chief financial officer owned 87,471 shares of the company’s stock, valued at $5,300,742.60. This represents a 3.93% increase in their ownership of the stock. Additional details regarding this purchase are available in the official SEC disclosure. Insiders have purchased a total of 21,847 shares of company stock worth $1,361,355 over the last three months. 0.36% of the stock is owned by corporate insiders.

Hedge Funds Weigh In On GE HealthCare Technologies

Several hedge funds and other institutional investors have recently modified their holdings of the stock. Allstate Corp increased its stake in GE HealthCare Technologies by 100.3% during the fourth quarter. Allstate Corp now owns 32,688 shares of the company’s stock worth $2,681,000 after acquiring an additional 16,365 shares during the last quarter. Temasek Holdings Private Ltd bought a new position in shares of GE HealthCare Technologies during the 3rd quarter valued at approximately $99,922,000. Waverton Investment Management Ltd increased its position in shares of GE HealthCare Technologies by 2.8% during the 3rd quarter. Waverton Investment Management Ltd now owns 1,086,668 shares of the company’s stock valued at $81,582,000 after purchasing an additional 29,897 shares during the last quarter. Nordea Investment Management AB lifted its position in GE HealthCare Technologies by 564.4% in the fourth quarter. Nordea Investment Management AB now owns 284,344 shares of the company’s stock worth $23,515,000 after buying an additional 241,548 shares during the last quarter. Finally, Salem Investment Counselors Inc. lifted its position in GE HealthCare Technologies by 9.2% in the fourth quarter. Salem Investment Counselors Inc. now owns 176,452 shares of the company’s stock worth $14,473,000 after buying an additional 14,867 shares during the last quarter. Hedge funds and other institutional investors own 82.06% of the company’s stock.

About GE HealthCare Technologies

GE HealthCare Technologies (NASDAQ: GEHC) is a global medical technology and diagnostics company that develops, manufactures and markets a broad range of products and services for healthcare providers. Its portfolio centers on diagnostic imaging systems, including MRI, CT, PET and X-ray modalities, as well as ultrasound equipment. The company also supplies patient monitoring and anesthesia delivery systems, interventional and surgical imaging solutions, and molecular imaging technologies used in both clinical care and research settings.

In addition to hardware, GE HealthCare offers software, analytics and lifecycle services aimed at improving clinical workflows and equipment uptime.